Archive for March 28th, 2012

AFFY OMONTYS approved. BNVI reverse split vote May + NBIX ALIM PSDV GENT AEZS RPRX NBY DVAX TRGT updates

Mar 28, 2012 No Comments by

Affymax, Inc. (Nasdaq:AFFY) and Takeda Pharmaceutical Company Limited announced that the FDA approved OMONTYS (peginesatide) Injection for the treatment of anemia due to chronic kidney disease (CKD) in adult patients on dialysis. OMONTYS is the only once-monthly erythropoiesis-stimulating agent (ESA) for anemia to be made available to the dialysis patient population in the United States. Bionovo, Inc. (OTCQB: […]

Daily News Read more